Search for distinctive markers in DNT and cortical grade II glioma in children: Same clinicopathological and molecular Entities?

Current Topics in Medicinal Chemistry

Volumn 12, Issue 15, 2012, Pages 1683-1692

  Padovani, Laëtitia ^a,b,c   Colin, Carole ^a,b   Fernandez, Carla ^a,b,c   de Paula, André Maues ^c   Mercurio, Sandy ^a,b   Scavarda, Didier ^c   Frassineti, Frédéric ^a,b   Adélaïde, José ^d,e   Loundou, Anderson ^c   Intagliata, Dominique ^a,b   Bouvier, Corinne ^a,b,c   Lena, Gabriel ^c   Birnbaum, Daniel ^d,e   Girard, Nadine ^c   Figarella Branger, Dominique ^a,b,c  

^a University of the Mediterranean Aix Marseille II   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^d INSERM   (France)

^e INSTITUT PAOLI CALMETTES   (France)

Author keywords

Biological and genetic markers; Dysembryoplasic neuroepithelial tumours (DNT); Glioneuronal element; IDH1 gene; Low grade glioma

Indexed keywords

ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2;

ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CHILD; CHROMOSOME DELETION; CONTROLLED STUDY; DISEASE COURSE; DNA SEQUENCE; DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR; EVENT FREE SURVIVAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENETIC ANALYSIS; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEUROEPITHELIOMA; NUCLEAR MAGNETIC RESONANCE; OVERALL SURVIVAL; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; SCHOOL CHILD;

BRAIN NEOPLASMS; CEREBRAL CORTEX; CHILD; DISEASE-FREE SURVIVAL; DNA MUTATIONAL ANALYSIS; GLIOMA; HUMANS; ISOCITRATE DEHYDROGENASE; MAGNETIC RESONANCE IMAGING; NEOPLASM GRADING; RETROSPECTIVE STUDIES; TERATOMA; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84867526612     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/156802612803531450     Document Type: Article

References (52)

1. Louis, DN.; Ohgaki, H.; Wiestler, OD.; Cavenee, WK.; Burger, PC.; Jouvet, A.; Scheithauer, BW.; Kleihues, P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol., 2007, 114(2), 97-109.
2. Luyken, C.; Blümcke, I.; Fimmers, R.; Urbach, H.; Elger, CE.; Wiestler, OD.; Schramm J. The spectrum of long-term epilepsyassociated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia, 2003, 44(6), 822-830.
3. Daumas-Duport, C.; Scheithauer, BW.; Chodkiewicz, JP.; Laws, ER.; Jr., Vedrenne C. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery, 1988, 23(5), 545-556.
4. Daumas-Duport, C.; Varlet, P.; Bacha, S.; Beuvon, F.; Cervera-Pierot, P.; Chodkiewicz JP. Dysembryoplastic neuroepithelial tumors: nonspecific histological forms -- a study of 40 cases. J Neurooncol., 1999, 41(3), 267-280.
5. Riemenschneider, MJ.; Jeuken, JW.; Wesseling, P.; Reifenberger, G. Molecular diagnostics of gliomas: state of the art. Acta Neuropathol., 2010, 116(6), 597-602.
6. Balss, J.; Meyer, J.; Mueller, W.; Korshunov, A.; Hartmann, C.; von Deimling, A. Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol., 2008, 116(6), 597-602.
7. Bleeker, FE.; Lamba, S.; Leenstra, S.; Troost, D.; Hulsebos, T.; Vandertop, WP.; Frattini, M.; Molinari, F.; Knowles, M.; Cerrato, A.; Rodolfo, M.; Scarpa, A.; Felicioni, L,; Buttitta, F.; Malatesta, S.; Marchetti, A.; Bardelli A. IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum. Mutat., 2009, 30(1), 7-11.
8. Parsons, D.W.; Jones, S.; Zhang, X.; Lin, J.C.; Leary, R.J.; Angenendt, P.; Mankoo, P.; Carter, H.; Siu, IM.; Gallia, G.L.; Olivi, A.; McLendon, R.; Rasheed, B.A.; Keir, S.; Nikolskaya, T.; Nikolsky, Y.; Busam, D.A.; Tekleab, H.; Diaz, L.A.; Jr, Hartigan, J.; Smith, D.R.; Strausberg, R.L.; Marie, S.K.; Shinjo, S.M.; Yan, H.; Riggins, GJ.; Bigner, D.D.; Karchin, R.; Papadopoulos, N.; Parmigiani, G.; Vogelstein, B.; Velculescu, V.E.; Kinzler, K. An integrated genomic analysis of human glioblastoma multiforme. Science., 2008, 321(5897), 1807-1812.
9. Yan, H.; Parsons, D.W.; Jin, G.; McLendon, R.; Rasheed, B.A.; Yuan, W.; Kos, I.; Batinic-Haberle, I.; Jones, S.; Riggins, G.J.; Friedman, H.; Friedman, A.; Reardon, D.; Herndon, J.; Kinzler, K.W.; Velculescu, V.E.; Vogelstein, B.; Bigner, D.D. IDH1 and IDH2 mutations in gliomas. N Engl J Med., 2009, 360(8), 765-773.
10. Watanabe, T.; Nobusawa, S.; Kleihues, P.; Ohgaki, H. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am. J. Pathol., 2009, 174(4), 1149-1153.
11. Metellus, P.; Coulibaly, B.; Colin, C.; de Paula, A.M.; Vasiljevic, A.; Taieb, D.; Barlier, A.; Boisselier, B.; Mokhtari, K.; Wang, X.W.; Loundou, A.; Chapon, F.; Pineau, S.; Ouafik, L.; Chinot, O.; Figarella-Branger D. Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis. Acta Neuropathol,. 2010, 120(6), 719-729.
12. Anker, L.; Ohgaki, H.; Ludeke, B.I.; Herrmann, H.D.; Kleihues, P.; Westphal, M. p53 protein accumulation and gene mutations in human glioma cell lines. Int J Cancer., 1993, 55(6) 982-987.
13. Peraud, A.; Kreth, FW.; Wiestler, OD.; Kleihues, P.; Reulen, HJ. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas. Clin Cancer Res., 2002, 8(5), 1117-1124.
14. Figarella-Branger, D.; Colin, C.; Coulibaly, B.; Quilichini, B.; Maues De Paula, A.; Fernandez, C.; Bouvier, C. Histological and molecular classification of gliomas. Rev Neurol., 2008, 164(6-7), 505-515.
15. Ohgaki, H.; Kleihues, P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol., 2007, 170(5), 1445-1453.
16. Okamoto, Y.; Di Patre, P.L.; Burkhard, C.; Horstmann, S.; Jourde, B.; Fahey, M.; Schüler, D.; Probst-Hensch, N.M.; Yasargil, M.G.; Yonekawa, Y.; Lütolf, U.M.; Kleihues, P.; Ohgaki, H. Populationbased study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol., 2004, 108(1), 49-56.
17. Capper, D.; Reuss, D.; Schittenhelm, J.; Hartmann, C.; Bremer, J.; Sahm, F.; Harter, P.N.; Jeibmann, A.; von Deimling, A. Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology. Acta Neuropathol., 2011, 121, 241-252.
18. Paugh, BS.; Qu, C.; Jones, C.; Liu, Z.; Adamowicz-Brice, M.; Zhang, J.; Bax, D.A.; Coyle, B.; Barrow, J.; Hargrave, D.; Lowe, J.; Gajjar, A.; Zhao, W.; Broniscer, A.; Ellison, D.W.; Grundy, R.G.; Baker, SJ. Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol., 2010, 20;28(18), 3061-3068.
19. Adélaïde, J.; Finetti, P.; Bekhouche, I.; Repellini, L.; Geneix, J.; Sircoulomb, F.; Charafe-Jauffret, E.; Cervera, N.; Desplans, J.; Parzy, D.; Schoenmakers, E.; Viens, P.; Jacquemier, J.; Birnbaum, D.; Bertucci, F.; Chaffanet M. Integrated profiling of basal and luminal breast cancers. Cancer Res., 2007, 67(24), 11565-11575.
20. Bouvier, C.; Roll, P.; Quilichini, B.; Metellus, P.; Calisti, A.; Gilles, S.; Chinot, O.; Fina, F.; Martin, PM.; Figarella-Branger, D. Deletions of chromosomes 1p and 19q are detectable on frozen smears of gliomas by FISH: usefulness for stereotactic biopsies. J Neurooncol., 2004, 68(2):141-149.
21. Palmini, A.; Najm, I.; Avanzini, G.; Babb, T.; Guerrini, R.; Foldvary-Schaefer, N.; Jackson, G.; Lüders, H.O.; Prayson, R.; Spreafico, R.; Vinters, H.V. Terminology and classification of the cortical dysplasias. Neurology., 2004, 62(6 Suppl 3), S2-8.
22. Daumas-Duport, C.; Varlet, P. Dysembryoplastic neuroepithelial tumors. Rev Neurol,. 2003, 159(6-7 Pt 1), 622-636.
23. Fernandez, C.; Girard, N.; Paz Paredes, A.; Bouvier-Labit, C.; Lena, G.; Figarella-Branger, D. The usefulness of MR imaging in the diagnosis of dysembryoplastic neuroepithelial tumor in children: a study of 14 cases. AJNR Am. J. Neuroradiol., 2003, 24(5), 829-834.
24. Maher, C.O.; White, J.B.; Scheithauer, B.W.; Raffel, C. Recurrence of dysembryoplastic neuroepithelial tumor following resection. Pediatr Neurosurg., 2008, 44(4), 333-336.
25. Nolan, M.A.; Sakuta, R.; Chuang, N.; Otsubo, H.; Rutka, J.T.; Snead, O.C 3rd.; Hawkins, C.E.; Weiss, SK. Dysembryoplastic neuroepithelial tumors in childhood: long-term outcome and prognostic features. Neurology., 2004, 62(12), 2270-2276.
26. Ray, WZ.; Blackburn, S.L.; Casavilca-Zambrano, S.; Barrionuevo, C.; Orrego, J.E.; Heinicke, H.; Dowling, J.L.; Perry, A. Clinicopathologic features of recurrent dysembryoplastic neuroepithelial tumor and rare malignant transformation: a report of 5 cases and review of the literature. J Neurooncol., 2009, 94(2), 283-292.
27. Qaddoumi, I.; Ellison, D.W.; Morris, E.B.; Broniscer, A.; Boop, F.; Merchant, T.; Palmer, S.L.; Gajjar, A. Dysembryoplastic neuroepithelial tumors and cognitive outcome: cure at a price? Cancer, 2010, 116(23), 5461-5469.
28. Gonzales, M.; Dale, S.; Susman, M.; Nolan, P.; Ng, WH.; Maixner, W.; Laidlaw, J. Dysembryoplastic neuroepithelial tumor (DNT)- like oligodendrogliomas or Dnts evolving into oligodendrogliomas: two illustrative cases. Neuropathology, 2007, 27(4), 324-330.
29. Hammond, R.R.; Duggal, N.; Woulfe, J.M.; Girvin, J.P. Malignant transformation of a dysembryoplastic neuroepithelial tumor. Case report. J Neurosurg., 2000, 92(4), 722-725.
30. Rushing, E.J.; Thompson, L.D.; Mena, H. Malignant transformation of a dysembryoplastic neuroepithelial tumor after radiation and chemotherapy. Ann Diagn. Pathol., 2003, 7(4), 240-244.
31. Broniscer, A.; Baker, S.J.; West, A.N.; Fraser, M.M.; Proko, E.; Kocak, M.; Dalton, J.; Zambetti, G.P.; Ellison, D.W.; Kun, L.E.; Gajjar, A.; Gilbertson, R.J.; Fuller CE. Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. J. Clin. Oncol., 2007, 25(6), 682-689.
32. Fisher, P.G.; Tihan, T.; Goldthwaite, P.T.; Wharam, M.D.; Carson, B.S.; Weingart, J.D.; Repka, M.X.; Cohen, K.J.; Burger, PC. Outcome analysis of childhood low-grade astrocytomas. Pediatr. Blood Cancer, 2008, 51(2), 245-250.
33. Hirsch, J.F.; Sainte Rose, C.; Pierre-Kahn, A.; Pfister, A.; Hoppe-Hirsch, E. Benign astrocytic and oligodendrocytic tumors of the cerebral hemispheres in children. J. Neurosurg., 1989, 70(4), 568-572.
34. Laws, E.R.; Jr., Taylor, WF.; Clifton, M.B.; Okazaki, H. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J. Neurosurg., 1984, 61(4), 665-673.
35. Pollack, I.F.; Claassen, D.; al-Shboul, Q.; Janosky, J.E.; Deutsch, M. Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. J. Neurosurg., 1995, 82(4), 536-547.
36. Fernandez, C.; Maues de Paula, A.; Colin, C.; Quilichini, B.; Bouvier-Labit, C.; Girard, N.; Scavarda, D.; Lena, G.; Figarella-Branger, D. Thalamic gliomas in children: an extensive clinical, neuroradiological and pathological study of 14 cases. Childs Nerv. Syst., 2006, 22(12), 1603-1610.
37. Lena, G.; Mottolese, C.; Paz-Paredes, A.; Scavarda, D.; Girard, N.; Gouvernet, J.; Jouvet, A.; Figarella-Branger, D. [Pediatric supratentorial oligodendrogliomas: Marseilles and Lyons experiences] Neurochirurgie, 2005, 51(3-4 Pt 2), 400-409.
38. Peters, O.; Gnekow, A.K.; Rating, D.; Wolff, JE. Impact of location on outcome in children with low-grade oligodendroglioma. Pediatr. Blood Cancer, 2004, 43(3), 250-256.
39. Ozlen, F.; Gunduz, A.; Asan, Z.; Tanriverdi, T.; Ozkara, C.; Yeni, N.; Yalcinkaya, C.; Ozyurt, E.; Uzan, M. Dysembryoplastic neuroepithelial tumors and gangliogliomas: clinical results of 52 patients. Acta Neurochir., 2010, 152(10), 1661-1671.
40. Minkin, K.; Klein, O.; Mancini, J.; Lena, G. Surgical strategies and seizure control in pediatric patients with dysembryoplastic neuroepithelial tumors: a single-institution experience. J. Neurosurg. Pediatr., 2008, 1(3), 206-210.
41. Hartmann, C.; Meyer, J.; Balss, J.; Capper, D.; Mueller, W.; Christians, A.; Felsberg, J.; Wolter, M.; Mawrin, C.; Wick, W.; Weller, M.; Herold-Mende, C.; Unterberg, A.; Jeuken, J.W.; Wesseling, P.; Reifenberger, G.; von Deimling, A. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol., 2009, 118(4), 469-474.
42. Labussière, M.; Idbaih, A.; Wang, X.W.; Marie, Y.; Boisselier, B.; Falet, C.; Paris, S.; Laffaire, J.; Carpentier, C.; Crinière, E.; Ducray, F.; El Hallani, S.; Mokhtari, K.; Hoang-Xuan, K.; Delattre, J.Y.; Sanson, M. All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2. Neurology, 2010, 74(23), 1886-1890.
43. De Carli, E.; Wang, X.; Puget, S. IDH1 and IDH2 mutations in gliomas. N Engl J Med., 2009, 360(21), 2248; author reply 2249.
44. Raghavan, R.; Balani, J.; Perry, A.; Margraf, L.; Vono, M.B.; Cai, D.X.; Wyatt, R.E.; Rushing, E.J.; Bowers, D.C.; Hynan, L.S.; White, C.L 3rd. Pediatric oligodendrogliomas: a study of molecular alterations on 1p and 19q using fluorescence in situ hybridization. J Neuropathol. Exp. Neurol., 2003, 62(5), 530-537.
45. Kreiger, P.A.; Okada, Y.; Simon, S.; Rorke, L.B.; Louis, D.N.; Golden, J.A.; Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas. Acta Neuropathol., 2005, 109(4), 387-392.
46. Prayson, R.A.; Castilla, E.A.; Hartke, M.; Pettay, J.; Tubbs, R.R.; Barnett, G.H. Chromosome 1p allelic loss by fluorescence in situ hybridization is not observed in dysembryoplastic neuroepithelial tumors. Am J Clin Pathol., 2002, 118(4), 512-517.
47. Fujisawa, H; Marukawa, K.; Hasegawa, M.; Tohma, Y.; Hayashi, Y.; Uchiyama, N.; Tachibana, O.; Yamashita, J. Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors. J. Neurosurg., 2002, 97(6), 1350-1355.
48. Nakamura, M.; Shimada, K.; Ishida, E.; Higuchi, T.; Nakase, H.; Sakaki, T.; Konishi, N. Molecular pathogenesis of pediatric astrocytic tumors. Neuro Oncol., 2007, 9(2), 113-123.
49. Pollack, I.F.; Finkelstein, S.D.; Woods, J.; Burnham, J.; Holmes, E.J.; Hamilton, R.L.; Yates, A.J.; Boyett, J.M.; Finlay, J.L.; Sposto, R.; Children's Cancer Group. Expression of p53 and prognosis in children with malignant gliomas. N. Engl. J. Med., 2002, 346(6), 420-427.
50. Hoischen, A.; Ehrler, M.; Fassunke, J.; Simon, M.; Baudis, M.; Landwehr, C.; Radlwimmer, B.; Lichter, P.; Schramm, J.; Becker, A.J.; Weber, R.G. Comprehensive characterization of genomic aberrations in gangliogliomas by CGH, array-based CGH and interphase FISH. Brain Pathol., 2008, 18(3), 326-337.
51. Weber, R.G.; Hoischen, A.; Ehrler, M.; Zipper, P.; Kaulich, K.; Blaschke, B.; Becker, A.J.; Weber-Mangal, S.; Jauch, A.; Radlwimmer, B.; Schramm, J.; Wiestler, O.D.; Lichter, P.; Reifenberger, G. Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas. Oncogene, 2007, 26(7), 1088-1097.
52. Campos, A.R.; Clusmann, H.; von Lehe, M.; Niehusmann, P.; Becker, A.J.; Schramm, J.; Urbach, H. Simple and complex dysembryoplastic neuroepithelial tumors (DNT) variants: clinical profile, MRI, and histopathology. Neuroradiology, 2009, 51(7), 433-443.